Mersana Therapeutics buy Citigroup Inc.
Start price
27.08.24
/
50%
€1.34
Target price
27.08.25
€4.48
Performance (%)
-84.11%
End price
28.08.25
-
Summary
This prediction is currently being closed. Massive losses of -84.11% have been the result for the BUY prediction by Citigroup_Inc_. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mersana Therapeutics | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Citigroup_Inc_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its price target lowered by analysts at Citigroup Inc. from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for MRSN provided by MarketBeat
In the thread Trading Mersana Therapeutics
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Citigroup_Inc_ for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€2.40
15.11.24
15.11.24
€4.74
15.11.25
15.11.25
-89.06%
16.11.25
16.11.25
Mersana Therapeutics
Start price
Target price
Perf. (%)
€1.71
04.12.23
04.12.23
€4.61
04.12.24
04.12.24
25.26%
05.12.24
05.12.24